Silva, Dina Lúcia Gomes daCardoso, SandraGuerreiro, ManuelaMarôco, J. P.Mendes, TiagoAlves, LuísaNogueira, Joana MaiaBaldeiras, InesSantana, IsabelMendonça, Alexandre de2020-04-302020-04-302020Journal of Alzheimer's Disease, 74(3), 785-796 Doi.:10.3233/JAD-19113313872877http://hdl.handle.net/10400.12/7553Fundação para a Ciência e TecnologiaDiagnosis of Alzheimer's disease (AD) confirmed by biomarkers allows the patient to make important life decisions. However, doubt about the fleetness of symptoms progression and future cognitive decline remains. Neuropsychological measures were extensively studied in prediction of time to conversion to dementia for mild cognitive impairment (MCI) patients in the absence of biomarker information. Similar neuropsychological measures might also be useful to predict the progression to dementia in patients with MCI due to AD.engAlzheimer’s diseaseCognitive impairmentAmyloidDementiaMild cognitive impairment due to ADNeuropsychological assessmentProdromalRaven Coloured Progressive Matricesjournal article10.3233/JAD-191133